Logo image of CBD

CIA BRASILEIRA DE DIS- ADR (CBD) Stock Earnings & Estimates

NYSE:CBD - US20440T3005 - ADR

0.445 USD
-0.01 (-3.05%)
Last: 4/18/2024, 8:04:00 PM
0.4357 USD
-0.01 (-2.09%)
After Hours: 4/18/2024, 8:04:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
CBD revenue by date.CBD revenue by date.
16.298B
-68.20%
17.321B
6.28%
19.25B
11.14%
21.612B
12.27%
22.673B
4.91%
24.109B
6.33%
27.966B
16.00%
EBITDA
YoY % growth
CBD ebitda by date.CBD ebitda by date.
2.434B
-54.12%
1.834B
-24.65%
1.233B
-32.77%
1.684B
36.58%
1.877B
11.46%
2.048B
9.11%
2.39B
16.70%
EBIT
YoY % growth
CBD ebit by date.CBD ebit by date.
317M
-88.43%
-68M
-121.45%
97M
242.65%
502.53M
418.07%
678.29M
34.98%
797.06M
17.51%
1.126B
41.27%
Operating Margin
CBD operating margin by date.CBD operating margin by date.
1.95%-0.39%0.50%2.33%2.99%3.31%4.03%
EPS
YoY % growth
CBD eps by date.CBD eps by date.
N/A
-15.54%
-0.35
-117.51%
-4.41
-1,171.43%
-0.72
83.74%
-0.37
48.56%
-0.24
34.25%
N/A

All data in BRL

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth
-0.23
54.35%
-0.20
69.79%
-0.16
93.84%
-0.04
93.35%
Revenue
Q2Q % growth
4.983B
10.83%
5.292B
11.29%
5.295B
11.66%
5.88B
11.85%
EBITDA
Q2Q % growth
376.7M
53.13%
405.96M
-23.98%
424.21M
-50.33%
546M
-57.81%
EBIT
Q2Q % growth
66.597M
295.87%
88.825M
386.53%
117.86M
2,846.50%
234.19M
48.22%

All data in BRL

Recent Earnings VS Estimates Surprises (BRL)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
-0.62
72.55%
-0.32-0.30-91.89%
Q3 2023
Q2Q % growth
-2.64
-335.45%
-0.47-2.16-455.83%
Q2 2023
Q2Q % growth
-0.66
-85.94%
-0.52-0.13-25.58%
Q1 2023
Q2Q % growth
-0.50
-117.53%
-0.11-0.39-341.75%
Q4 2022
Q2Q % growth
-2.25
-241.77%
0.28-2.53-897.54%
Q3 2022
Q2Q % growth
-0.61
-789.97%
-0.09-0.52-567.48%
Q2 2022
Q2Q % growth
-0.35
-6,500.00%
-0.06-0.29-491.77%
Q1 2022
Q2Q % growth
2.86
1,135.71%
3.96-1.10-27.71%
Q4 2021
Q2Q % growth
1.59
-51.55%
0.441.14258.23%
Q3 2021
Q2Q % growth

-108.77%
-0.07%
Q2 2021
Q2Q % growth
0.01
-99.19%
0.08-0.07-93.07%
Q1 2021
Q2Q % growth
0.23 0.040.19443.69%
Q4 2020
Q2Q % growth
3.27
1,163.83%
1.481.80121.52%
Q3 2020
Q2Q % growth
0.78
143.10%
0.650.1219.04%
Q2 2020
Q2Q % growth
0.68
-22.98%
0.310.37120.22%
Q4 2019
Q2Q % growth
0.26 0.74-0.48-65.17%
Q3 2019
Q2Q % growth
0.32 0.53-0.21-40.10%
Q2 2019
Q2Q % growth
0.89 0.500.3977.63%
Q1 2019
Q2Q % growth
0.30 0.51-0.20-40.23%
CBD Yearly EPS VS EstimatesCBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4
Recent Revenue VS Estimates Surprises (BRL)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
5.257B
-69.65%
5.446B-189M-3.47%
Q3 2023
Q2Q % growth
4.742B
-54.63%
4.957B-215M-4.34%
Q2 2023
Q2Q % growth
4.755B
-53.00%
8.045B-3.29B-40.89%
Q1 2023
Q2Q % growth
4.496B
-55.35%
11.181B-6.685B-59.79%
Q4 2022
Q2Q % growth
17.321B
6.28%
12.679B4.642B36.61%
Q3 2022
Q2Q % growth
10.451B
8.93%
10.804B-353M-3.27%
Q2 2022
Q2Q % growth
10.116B
9.34%
10.085B31M0.31%
Q1 2022
Q2Q % growth
10.069B
2.30%
10.088B-19M-0.19%
Q4 2021
Q2Q % growth
16.298B
-68.20%
14.895B1.403B9.42%
Q3 2021
Q2Q % growth
9.594B
-20.47%
10.48B-886M-8.45%
Q2 2021
Q2Q % growth
9.252B
-26.24%
16.213B-6.961B-42.93%
Q1 2021
Q2Q % growth
9.843B
-17.12%
10.111B-268M-2.65%
Q4 2020
Q2Q % growth
51.253B
77.73%
21.952B29.301B133.48%
Q3 2020
Q2Q % growth
12.064B
-10.80%
21.43B-9.366B-43.71%
Q2 2020
Q2Q % growth
12.543B
-4.11%
20.948B-8.405B-40.12%
Q1 2020
Q2Q % growth
11.876B
-10.70%
%
Q4 2019
Q2Q % growth
28.838B 16.014B12.824B80.08%
Q3 2019
Q2Q % growth
13.524B 14.178B-654M-4.61%
Q2 2019
Q2Q % growth
13.081B 13.571B-490M-3.61%
CBD Yearly Revenue VS EstimatesCBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS54.81% 58.85% 49.53% 46.14%
Revenue-0.72% -1.13% 0.22% -1.27%